Treatment of local recurrence of esophageal cancer following Ivor‐Lewis esophagectomy—Experiences of a high‐volume center

Documenti analoghi

• Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapy
  di: Max Kraemer, et al.
  Pubblicazione: (2025)
• Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro‐inflammatory tumor microenvironment in esophageal adenocarcinoma
  di: Bastian Grothey, et al.
  Pubblicazione: (2026)
• Exploration of histone protein γ‐H2AX as a prognostic factor in soft tissue sarcomas and its association with biological behavior, immune cell environment and survival in leiomyosarcoma
  di: Adrian Georg Simon, et al.
  Pubblicazione: (2024)
• Salvage esophagectomy for unresectable locally advanced esophageal squamous cell carcinoma: Significant or not?
  di: Hiroshi Saeki, et al.
  Pubblicazione: (2025)
• Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma
  di: Naita Maren Wirsik, et al.
  Pubblicazione: (2024)